ono 1078 has been researched along with Premature Birth in 1 studies
pranlukast: SRS-A antagonist; leukotriene D4 receptor antagonist
Premature Birth: CHILDBIRTH before 37 weeks of PREGNANCY (259 days from the first day of the mother's last menstrual period, or 245 days after FERTILIZATION).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hatakeyama, S | 1 |
| Goto, M | 1 |
| Yamamoto, A | 1 |
| Ogura, J | 1 |
| Watanabe, N | 1 |
| Tsutsumi, S | 1 |
| Yakuwa, N | 1 |
| Yamane, R | 1 |
| Nagase, S | 1 |
| Takahashi, K | 1 |
| Kosaki, R | 1 |
| Murashima, A | 1 |
| Yamaguchi, H | 1 |
1 other study available for ono 1078 and Premature Birth
| Article | Year |
|---|---|
The safety of pranlukast and montelukast during the first trimester of pregnancy: A prospective, two-centered cohort study in Japan.
Topics: Abortion, Spontaneous; Acetates; Chromones; Cohort Studies; Cyclopropanes; Female; Humans; Infant, N | 2022 |